Name: Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (en Inglés)
Price: 228.86 USD
Availability: InStock
Author: Rezaei, Nima
ISBN: 9783030579517

portada Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Rezaei, Nima

Idioma

Inglés

N° páginas

581

Encuadernación

Tapa Blanda

ISBN13

9783030579517

N° edición

0002

Categorías

Oncología
Hematología

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (en Inglés)

Rezaei, Nima (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 228.86

$ 452.16

Ahorras: $ 223.31

49% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 23 de Julio y el Miércoles 31 de Julio.

Lo recibirás en cualquier lugar de Ecuador entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (en Inglés)"

This book explains the immunology of organ-specific malignancies and discusses novel immunotherapy strategies for their treatment. Since the first, very successful edition of the book was published in 2015, a number of entirely new chapters have been included. The range of cancers considered has accordingly been extended, with coverage of the latest immunotherapy approaches for cancers in different organs. In addition, the original chapters have been updated to document the latest advances in immunotherapy for pediatric solid tumors, hematologic malignancies, gastrointestinal tumors, bone tumors, central nervous tumors, lung cancer, genitourinary tract tumors, and breast cancer, among others. The book is published as part of the three-volume Springer series Cancer Immunology, which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Other volumes in the series address the translational medicine context and bench to bedside immunotherapy. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors will be of special value to clinical immunologists, hematologists, and oncologists.